S. Ogawa et al., INCREASED EVI-1 EXPRESSION IS FREQUENTLY OBSERVED IN BLASTIC CRISIS OF CHRONIC MYELOCYTIC-LEUKEMIA, Leukemia, 10(5), 1996, pp. 788-794
Evi-1 is a transforming gene originally identified in a common integra
tion site of murine leukemia retrovirus and mapped in human chromosome
3q26. It is not normally expressed in either human or murine hematopo
ietic cells, but is overexpressed in retrovirus-induced murine myeloid
leukemias as well as human myeloid leukemias with 3q26 abnormalities,
and thus thought to be responsible for both human and murine leukemog
enesis. In this study, possible involvement of the Evi-1 gene in human
leukemias was evaluated by Northern blot analysis in a total of 73 pa
tients with various types of leukemias. We found that increased expres
sion of the Evi-1 gene was most frequently observed in patients with C
ML In blastic crisis, It was found in 10 of 14 (71.0%) samples from CM
L in blastic crisis, three of 15(20.0%) from acute myelocytic leukemia
, three of 11 (27.3%) from MDS-derived leukemia, and one of 11 (9.1%)
from acute lymphoblastic leukemia. Among 18 patients showing increased
Evi-1 expression, none of 17 informative patients showed cytogenetic
abnormalities involving 3q26. In addition, Southern blot analysis reve
aled neither amplification nor rearrangements of the Evi-1 gene in 11
Evi-1-positive patients whose DNA samples were available. Our results
suggest that increased expression of the Evi-1 gene may play an import
ant role in development of human leukemias, especially in progression
from chronic phase to blastic crisis of CML even without 3q26 abnormal
ities.